For Kodak, July 29 looked like a miracle. The beleaguered film company's stock, which started the week at $2.10, was soaring — at one point reaching $60. The market was reacting to the news that the Trump administration was loaning the company $765 million to enter the generic pharmaceutical business.
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to log in.